Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Enfinity Global & ICG complete €400 million equity agreement 2023-10-25 21:32
Xailient and Morse Micro Join Forces to Transform the Future of Smart Cameras 2023-10-25 21:05
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis 2023-10-23 21:30
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston 2023-10-13 20:00
AACR OVARIAN CANCER CONFERENCE PRESENTATION 2023-10-09 15:18
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial 2023-10-03 20:58
FlexRule's Decision-Centric Approach® methodology empowers organizations to make quality decisions, fast 2023-09-28 12:32
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update 2023-09-26 20:51
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT 2023-09-21 19:30
Körber celebrates partnership milestone with Geek+ 2023-09-20 18:34
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer 2023-09-11 15:00
World Orphan Drug Alliance Welcomes Specialised Therapeutics 2023-09-08 04:00
Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet. 2023-09-05 15:00
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001 2023-09-05 14:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
Noodoe Links Californian and Australian Efforts to Combat Global Climate Change 2023-08-18 03:47
THE CONQUEROR TEAMS UP WITH WARNER BROS. DISCOVERY GLOBAL CONSUMER PRODUCTS TO LAUNCH THE ULTIMATE SERIES OF VIRTUAL FITNESS CHALLENGES INSPIRED BY HBO'S GAME OF THRONES 2023-08-16 14:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
HB11 Energy receives grant from US Department of Energy to develop clean, safe and unlimited fusion energy 2023-08-15 21:00
Clarity's theranostic prostate cancer trial advances to highest dose level 2023-08-10 20:58
1 12 13 14 15 16 120